{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:37:19Z","timestamp":1763415439079,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41418-018-0112-9","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T10:46:25Z","timestamp":1525862785000},"page":"1536-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antigen-specific primed cytotoxic T cells eliminate tumour cells in vivo and prevent tumour development, regardless of the presence of anti-apoptotic mutations conferring drug resistance"],"prefix":"10.1038","volume":"25","author":[{"given":"Paula","family":"Jaime-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iratxe","family":"Uranga-Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nacho","family":"Aguil\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llipsy","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"M Lanuza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maykel","family":"A Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-0730","authenticated-orcid":false,"given":"Juli\u00e1n","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"112_CR1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15:388\u2013400.","journal-title":"Nat Rev Immunol"},{"key":"112_CR2","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1158\/1078-0432.CCR-15-0685","volume":"21","author":"L Martinez-Lostao","year":"2015","unstructured":"Martinez-Lostao L, Anel A, Pardo J. How Do Cytotoxic Lymphocytes Kill Cancer Cells? Clin Cancer Res. 2015;21:5047\u201356.","journal-title":"Clin Cancer Res"},{"key":"112_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0105-2896.2010.00908.x","volume":"235","author":"IS Afonina","year":"2010","unstructured":"Afonina IS, Cullen SP, Martin SJ. Cytotoxic and non-cytotoxic roles of the CTL\/NK protease granzyme B. Immunol Rev. 2010;235:105\u201316.","journal-title":"Immunol Rev"},{"key":"112_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0952-7915(03)00107-9","volume":"15","author":"JA Trapani","year":"2003","unstructured":"Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol. 2003;15:533\u201343.","journal-title":"Curr Opin Immunol"},{"key":"112_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prca.201300096","volume":"8","author":"LT Joeckel","year":"2014","unstructured":"Joeckel LT, Bird PI. Blessing or curse? Proteomics in granzyme research. Proteom Clin Appl. 2014;8:351\u201381.","journal-title":"Proteom Clin Appl"},{"key":"112_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.0909608","volume":"87","author":"S Hoves","year":"2010","unstructured":"Hoves S, Trapani JA, Voskoboinik I. The battlefield of perforin\/granzyme cell death pathways. J Leukoc Biol. 2010;87:237\u201343.","journal-title":"J Leukoc Biol"},{"key":"112_CR7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/377446a0","volume":"377","author":"AJ Darmon","year":"1995","unstructured":"Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 1995;377:446\u20138.","journal-title":"Nature"},{"key":"112_CR8","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/MCB.20.11.3781-3794.2000","volume":"20","author":"M Barry","year":"2000","unstructured":"Barry M, Heibein JA, Pinkoski MJ, Lee SF, Moyer RW, Green DR, et al. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol. 2000;20:3781\u201394.","journal-title":"Mol Cell Biol"},{"key":"112_CR9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.192.10.1403","volume":"192","author":"VR Sutton","year":"2000","unstructured":"Sutton VR, Davis JE, Cancilla M, Johnstone RW, Ruefli AA, Sedelies K, et al. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med. 2000;192:1403\u201314.","journal-title":"J Exp Med"},{"key":"112_CR10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/icb.2017.35","volume":"95","author":"LT Joeckel","year":"2017","unstructured":"Joeckel LT, Allison CC, Pellegrini M, Bird CH, Bird PI. Granzyme K-deficient mice show no evidence of impaired anti-viral immunity. Immunol Cell Biol. 2017;95:676\u201383.","journal-title":"Immunol Cell Biol"},{"key":"112_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.immunol.26.021607.090404","volume":"26","author":"D Chowdhury","year":"2008","unstructured":"Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol. 2008;26:389\u2013420.","journal-title":"Annu Rev Immunol"},{"key":"112_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.it.2009.01.002","volume":"30","author":"CJ Froelich","year":"2009","unstructured":"Froelich CJ, Pardo J, Simon MM. Granule-associated serine proteases: granzymes might not just be killer proteases. Trends Immunol. 2009;30:117\u201323.","journal-title":"Trends Immunol"},{"key":"112_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/hsz-2013-0238","volume":"395","author":"LT Joeckel","year":"2014","unstructured":"Joeckel LT, Bird PI. Are all granzymes cytotoxic in vivo? Biol Chem. 2014;395:181\u2013202.","journal-title":"Biol Chem"},{"key":"112_CR14","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.181.5.1917","volume":"181","author":"M Irmler","year":"1995","unstructured":"Irmler M, Hertig S, MacDonald HR, Sadoul R, Becherer JD, Proudfoot A, et al. Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med. 1995;181:1917\u201322.","journal-title":"J Exp Med"},{"key":"112_CR15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.immuni.2008.08.014","volume":"29","author":"SS Metkar","year":"2008","unstructured":"Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity. 2008;29:720\u201333.","journal-title":"Immunity"},{"key":"112_CR16","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/cdd.2011.5","volume":"18","author":"LT Joeckel","year":"2011","unstructured":"Joeckel LT, Wallich R, Martin P, Sanchez-Martinez D, Weber FC, Martin SF, et al. Mouse granzyme K has pro-inflammatory potential. Cell Death Differ. 2011;18:1112\u20139.","journal-title":"Cell Death Differ"},{"key":"112_CR17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.celrep.2014.06.012","volume":"8","author":"MA Arias","year":"2014","unstructured":"Arias MA, Jimenez de Bagues MP, Aguilo N, Menao S, Hervas-Stubbs S, de Martino A, et al. Elucidating sources and roles of granzymes A and B during bacterial infection and sepsis. Cell Rep. 2014;8:420\u20139.","journal-title":"Cell Rep"},{"key":"112_CR18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.39857","volume":"69","author":"L Santiago","year":"2017","unstructured":"Santiago L, Menaa C, Arias M, Martin P, Jaime-Sanchez P, Metkar S, et al. Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis. Arthritis Rheumatol. 2017;69:320\u201334.","journal-title":"Arthritis Rheumatol"},{"key":"112_CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4049\/jimmunol.1401214","volume":"194","author":"AC Wensink","year":"2015","unstructured":"Wensink AC, Hack CE, Bovenschen N. Granzymes Regulate Proinflammatory Cytokine Responses. J Immunol. 2015;194:491\u20137.","journal-title":"J Immunol"},{"key":"112_CR20","doi-asserted-by":"crossref","first-page":"e1006155","DOI":"10.1371\/journal.ppat.1006155","volume":"13","author":"JA Wilson","year":"2017","unstructured":"Wilson JA, Prow NA, Schroder WA, Ellis JJ, Cumming HE, Gearing LJ, et al. RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation. PLoS Pathog. 2017;13:e1006155.","journal-title":"PLoS Pathog"},{"key":"112_CR21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.cdd.4402289","volume":"15","author":"J Pardo","year":"2008","unstructured":"Pardo J, Wallich R, Martin P, Urban C, Rongvaux A, Flavell RA, et al. Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs. Cell Death Differ. 2008;15:567\u201379.","journal-title":"Cell Death Differ"},{"key":"112_CR22","doi-asserted-by":"crossref","first-page":"e991613","DOI":"10.4161\/2162402X.2014.991613","volume":"4","author":"D Sanchez-Martinez","year":"2015","unstructured":"Sanchez-Martinez D, Azaceta G, Muntasell A, Aguilo N, Nunez D, Galvez EM, et al. Human NK cells activated by EBV+lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells. Oncoimmunology. 2015;4:e991613.","journal-title":"Oncoimmunology"},{"key":"112_CR23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2016.00454","volume":"7","author":"D Sanchez-Martinez","year":"2016","unstructured":"Sanchez-Martinez D, Lanuza PM, Gomez N, Muntasell A, Cisneros E, Moraru M, et al. Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells. Front Immunol. 2016;7:454.","journal-title":"Front Immunol"},{"key":"112_CR24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2014.11.012","volume":"41","author":"MD Prakash","year":"2014","unstructured":"Prakash MD, Munoz MA, Jain R, Tong PL, Koskinen A, Regner M, et al. Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling. Immunity. 2014;41:960\u201372.","journal-title":"Immunity"},{"key":"112_CR25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, et al. Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance. Immunity. 2007;27:635\u201346.","journal-title":"Immunity"},{"key":"112_CR26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/icb.2010.5","volume":"88","author":"JI Aguilo","year":"2010","unstructured":"Aguilo JI, Anel A, Catalan E, Sebastian A, Acin-Perez R, Naval J, et al. Granzyme B of cytotoxic T cells induces extramitochondrial reactive oxygen species production via caspase-dependent NADPH oxidase activation. Immunol Cell Biol. 2010;88:545\u201354.","journal-title":"Immunol Cell Biol"},{"key":"112_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313\u201321.","journal-title":"Nat Chem Biol"},{"key":"112_CR28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505:509\u201314.","journal-title":"Nature"},{"key":"112_CR29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1006\/cyto.1997.0252","volume":"9","author":"D Vercammen","year":"1997","unstructured":"Vercammen D, Vandenabeele P, Beyaert R, Declercq W, Fiers W. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine. 1997;9:801\u20138.","journal-title":"Cytokine"},{"key":"112_CR30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.449","volume":"4","author":"D Lecis","year":"2013","unstructured":"Lecis D, De Cesare M, Perego P, Conti A, Corna E, Drago C, et al. Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity. Cell Death Dis. 2013;4:e920.","journal-title":"Cell Death Dis"},{"key":"112_CR31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/mp4004578","volume":"11","author":"L Gatti","year":"2014","unstructured":"Gatti L, De Cesare M, Ciusani E, Corna E, Arrighetti N, Cominetti D, et al. Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma. Mol Pharm. 2014;11:283\u201393.","journal-title":"Mol Pharm"},{"key":"112_CR32","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.4049\/jimmunol.178.9.5727","volume":"178","author":"DK Cole","year":"2007","unstructured":"Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol. 2007;178:5727\u201334.","journal-title":"J Immunol"},{"key":"112_CR33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2567.2008.03015.x","volume":"126","author":"JD Stone","year":"2009","unstructured":"Stone JD, Chervin AS, Kranz DM. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology. 2009;126:165\u201376.","journal-title":"Immunology"},{"key":"112_CR34","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1074\/jbc.M509361200","volume":"281","author":"C Adrain","year":"2006","unstructured":"Adrain C, Duriez PJ, Brumatti G, Delivani P, Martin SJ. The cytotoxic lymphocyte protease, granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics. J Biol Chem. 2006;281:8118\u201325.","journal-title":"J Biol Chem"},{"key":"112_CR35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1083\/jcb.200612025","volume":"176","author":"SP Cullen","year":"2007","unstructured":"Cullen SP, Adrain C, Luthi AU, Duriez PJ, Martin SJ. Human and murine granzyme B exhibit divergent substrate preferences. J Cell Biol. 2007;176:435\u201344.","journal-title":"J Cell Biol"},{"key":"112_CR36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.200606073","volume":"175","author":"D Kaiserman","year":"2006","unstructured":"Kaiserman D, Bird CH, Sun J, Matthews A, Ung K, Whisstock JC, et al. The major human and mouse granzymes are structurally and functionally divergent. J Cell Biol. 2006;175:619\u201330.","journal-title":"J Cell Biol"},{"key":"112_CR37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1139\/o05-146","volume":"83","author":"RC Bleackley","year":"2005","unstructured":"Bleackley RC. A molecular view of cytotoxic T lymphocyte induced killing. Biochem Cell Biol. 2005;83:747\u201351.","journal-title":"Biochem Cell Biol"},{"key":"112_CR38","doi-asserted-by":"crossref","first-page":"14985","DOI":"10.1073\/pnas.261581498","volume":"98","author":"DA Thomas","year":"2001","unstructured":"Thomas DA, Scorrano L, Putcha GV, Korsmeyer SJ, Ley TJ. Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK. Proc Natl Acad Sci USA. 2001;98:14985\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"112_CR39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/tan.12014","volume":"80","author":"O Susanto","year":"2012","unstructured":"Susanto O, Trapani JA, Brasacchio D. Controversies in granzyme biology. Tissue Antigens. 2012;80:477\u201387.","journal-title":"Tissue Antigens"},{"key":"112_CR40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/cdd.2009.206","volume":"17","author":"SP Cullen","year":"2010","unstructured":"Cullen SP, Brunet M, Martin SJ. Granzymes in cancer and immunity. Cell Death Differ. 2010;17:616\u201323.","journal-title":"Cell Death Differ"},{"key":"112_CR41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1","volume":"31","author":"JE Davis","year":"2001","unstructured":"Davis JE, Smyth MJ, Trapani JA. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity. Eur J Immunol. 2001;31:39\u201347.","journal-title":"Eur J Immunol"},{"key":"112_CR42","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K","volume":"32","author":"J Pardo","year":"2002","unstructured":"Pardo J, Balkow S, Anel A, Simon MM. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol. 2002;32:2881\u20137.","journal-title":"Eur J Immunol"},{"key":"112_CR43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4049\/jimmunol.171.2.515","volume":"171","author":"MJ Smyth","year":"2003","unstructured":"Smyth MJ, Street SE, Trapani JA. Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol. 2003;171:515\u20138.","journal-title":"J Immunol"},{"key":"112_CR44","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.4049\/jimmunol.174.4.2124","volume":"174","author":"PA Revell","year":"2005","unstructured":"Revell PA, Grossman WJ, Thomas DA, Cao X, Behl R, Ratner JA, et al. Granzyme B and the downstream granzymes C and\/or F are important for cytotoxic lymphocyte functions. J Immunol. 2005;174:2124\u201331.","journal-title":"J Immunol"},{"key":"112_CR45","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/0008-5472.CAN-05-3377","volume":"66","author":"R Ravi","year":"2006","unstructured":"Ravi R, Fuchs EJ, Jain A, Pham V, Yoshimura K, Prouser T, et al. Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling. Cancer Res. 2006;66:1730\u20139.","journal-title":"Cancer Res"},{"key":"112_CR46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(03)00050-5","volume":"18","author":"VR Sutton","year":"2003","unstructured":"Sutton VR, Wowk ME, Cancilla M, Trapani JA. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity. 2003;18:319\u201329.","journal-title":"Immunity"},{"key":"112_CR47","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1074\/jbc.M606564200","volume":"282","author":"L Casciola-Rosen","year":"2006","unstructured":"Casciola-Rosen L, Garcia-Calvo M, Bull HG, Becker JW, Hines T, Thornberry NA, et al. Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the Bid pathway. J Biol Chem. 2006;282:4545\u201352.","journal-title":"J Biol Chem"},{"key":"112_CR48","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1074\/jbc.M606564200","volume":"282","author":"L Casciola-Rosen","year":"2007","unstructured":"Casciola-Rosen L, Garcia-Calvo M, Bull HG, Becker JW, Hines T, Thornberry NA, et al. Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway. J Biol Chem. 2007;282:4545\u201352.","journal-title":"J Biol Chem"},{"key":"112_CR49","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.4049\/jimmunol.158.12.5783","volume":"158","author":"VR Sutton","year":"1997","unstructured":"Sutton VR, Vaux DL, Trapani JA. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J Immunol. 1997;158:5783\u201390.","journal-title":"J Immunol"},{"key":"112_CR50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc3973","volume":"15","author":"I Melero","year":"2015","unstructured":"Melero I, Berman DM, Aznar MA, Korman AJ, Perez Gracia JL, Haanen J. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer. 2015;15:457\u201372.","journal-title":"Nat Rev Cancer"},{"key":"112_CR51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"112_CR52","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2016.07.145","volume":"43","author":"C Franklin","year":"2017","unstructured":"Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D. Immunotherapy in melanoma: Recent advances and future directions. Eur J Surg Oncol. 2017;43:604\u201311.","journal-title":"Eur J Surg Oncol"},{"key":"112_CR53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.currproblcancer.2016.12.002","volume":"41","author":"R Kumar","year":"2017","unstructured":"Kumar R, Collins D, Dolly S, McDonald F, O\u2019Brien MER, Yap TA. Targeting the PD-1\/PD-L1 axis in non-small cell lung cancer. Curr Probl Cancer. 2017;41:111\u201324.","journal-title":"Curr Probl Cancer"},{"key":"112_CR54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.21037\/tlcr.2017.03.01","volume":"6","author":"J Malhotra","year":"2017","unstructured":"Malhotra J, Jabbour SK, Aisner J. Current state of immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res. 2017;6:196\u2013211.","journal-title":"Transl Lung Cancer Res"},{"key":"112_CR55","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2015.07.045","volume":"162","author":"JD Wolchok","year":"2015","unstructured":"Wolchok JD. PD-1 Blockers. Cell. 2015;162:937.","journal-title":"Cell"},{"key":"112_CR56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder EI, Desai A. CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. Am J Clin Oncol. 2016;39:98\u2013106.","journal-title":"Am J Clin Oncol"},{"key":"112_CR57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.10248","volume":"99","author":"E Heere-Ress","year":"2002","unstructured":"Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP, et al. Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. Int J Cancer. 2002;99:29\u201334.","journal-title":"Int J Cancer"},{"key":"112_CR58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004030050479","volume":"292","author":"U Leiter","year":"2000","unstructured":"Leiter U, Schmid RM, Kaskel P, Peter RU, Krahn G. Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma. Arch Dermatol Res. 2000;292:225\u201332.","journal-title":"Arch Dermatol Res"},{"key":"112_CR59","first-page":"661","volume":"28","author":"H Zhang","year":"2006","unstructured":"Zhang H, Rosdahl I. Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis. Int J Oncol. 2006;28:661\u20136.","journal-title":"Int J Oncol"},{"key":"112_CR60","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.3800750","volume":"20","author":"L Zhuang","year":"2007","unstructured":"Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, Thompson JF, et al. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Mod Pathol. 2007;20:416\u201326.","journal-title":"Mod Pathol"},{"key":"112_CR61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lungcan.2005.08.010","volume":"51","author":"B Karczmarek-Borowska","year":"2006","unstructured":"Karczmarek-Borowska B, Filip A, Wojcierowski J, Smolen A, Korobowicz E, Korszen-Pilecka I, et al. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer. Lung Cancer. 2006;51:61\u201369.","journal-title":"Lung Cancer"},{"key":"112_CR62","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1158\/0008-5472.CAN-12-2272","volume":"73","author":"D Park","year":"2013","unstructured":"Park D, Magis AT, Li R, Owonikoko TK, Sica GL, Sun SY, et al. Novel small-molecule inhibitors of Bcl-XL to treat lung cancer. Cancer Res. 2013;73:5485\u201396.","journal-title":"Cancer Res"},{"key":"112_CR63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.lungcan.2006.07.012","volume":"54","author":"SG Sanchez-Ceja","year":"2006","unstructured":"Sanchez-Ceja SG, Reyes-Maldonado E, Vazquez-Manriquez ME, Lopez-Luna JJ, Belmont A, Gutierrez-Castellanos S. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma. Lung Cancer. 2006;54:163\u20138.","journal-title":"Lung Cancer"},{"key":"112_CR64","doi-asserted-by":"crossref","first-page":"e0136023","DOI":"10.1371\/journal.pone.0136023","volume":"10","author":"LH Schmidt","year":"2015","unstructured":"Schmidt LH, Kummel A, Gorlich D, Mohr M, Brockling S, Mikesch JH, et al. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. PLoS One. 2015;10:e0136023.","journal-title":"PLoS One"},{"key":"112_CR65","doi-asserted-by":"crossref","first-page":"13274","DOI":"10.1021\/bi010574w","volume":"40","author":"SJ Riedl","year":"2001","unstructured":"Riedl SJ, Renatus M, Snipas SJ, Salvesen GS. Mechanism-based inactivation of caspases by the apoptotic suppressor p35. Biochemistry. 2001;40:13274\u201380.","journal-title":"Biochemistry"},{"key":"112_CR66","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1074\/jbc.M114.631564","volume":"290","author":"E Catalan","year":"2014","unstructured":"Catalan E, Jaime-Sanchez P, Aguilo N, Simon MM, Froelich CJ, Pardo J. Mouse cytotoxic T cell-derived granzyme B activates the mitochondrial cell death pathway in a Bim dependent fashion. J Biol Chem. 2014;290:6868\u201377.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41418-018-0112-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-018-0112-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-018-0112-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T14:26:54Z","timestamp":1693664814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-018-0112-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1038\/s41418-018-0112-9","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"type":"print","value":"1350-9047"},{"type":"electronic","value":"1476-5403"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}